Astrana Health Sees 56% Revenue Surge

By Chris Stiles • Monday, March 02 10:56 • Permanent Link

Astrana Health, Inc. has reported its financial results for the fourth quarter and year end of 2025. The company's total revenue for the year ended December 31, 2025, was $3,181.8 million, showing a significant increase of 56% from $2,034.5 million in the previous year. Care partners revenue also saw a substantial rise of 55%, reaching $3,022.6 million, up from $1,949.0 million in 2024.

The adjusted EBITDA for the year ended 2025 was reported at $205.4 million, marking a 21% increase from $170.4 million in the previous year. The company's free cash flow amounted to $104.5 million.

In the fourth quarter of 2025, Astrana Health reported total revenue of $950.5 million, up by 43% from $665.2 million in the fourth quarter of 2024. The care partners revenue for the same period was $892.5 million, showing a 38% increase from $647.7 million.

The net income attributable to Astrana for the year ended 2025 was $22.5 million, and the diluted earnings per share (EPS) stood at $0.46. The adjusted EPS * diluted was reported at $2.20.

Furthermore, the adjusted EBITDA for the fourth quarter of 2025 was $52.5 million, marking a substantial increase of 50% from $35.0 million in the fourth quarter of 2024. The adjusted EPS * diluted for the same period was reported at $0.54.

The company also provided guidance for the three months ending March 31, 2026, and the year ending December 31, 2026. Astrana expects total revenue for the year ending December 31, 2026, to be in the range of $3,800 to $4,100 million, with adjusted EBITDA in the range of $250 to $280 million.

Astrana Health, Inc. is confident in its ability to deliver on guidance, reflecting approximately 24% revenue growth and 29% adjusted EBITDA growth at the midpoint as it moves through 2026. The company highlighted its record revenue, adjusted EBITDA, and free cash flow in 2025, demonstrating the strength and predictability of its fully delegated, payer-agnostic care model and AI-enabled technology platform in a dynamic operating environment. Today the company's shares have moved -1.57% to a price of $26.95. Check out the company's full 8-K submission here.

The above analysis is intended for educational purposes only and was performed on the basis of publicly available data. It is not to be construed as a recommendation to buy or sell any security. Any buy, sell, or other recommendations mentioned in the article are direct quotations of consensus recommendations from the analysts covering the stock, and do not represent the opinions of Market Inference or its writers. Past performance, accounting data, and inferences about market position and corporate valuation are not reliable indicators of future price movements. Market Inference does not provide financial advice. Investors should conduct their own review and analysis of any company of interest before making an investment decision.